158 related articles for article (PubMed ID: 26892695)
1. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
Ugwu IA; Oluwasola TA; Enabor OO; Anayochukwu-Ugwu NN; Adeyemi AB; Olayemi OO
Int J Gynaecol Obstet; 2016 May; 133(2):173-7. PubMed ID: 26892695
[TBL] [Abstract][Full Text] [Related]
2. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
Chaudhuri P; Biswas J; Mandal A
Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
[TBL] [Abstract][Full Text] [Related]
3. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
[TBL] [Abstract][Full Text] [Related]
4. Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.
Tewatia R; Rani S; Srivastav U; Makhija B
Arch Gynecol Obstet; 2014 Apr; 289(4):739-42. PubMed ID: 24045979
[TBL] [Abstract][Full Text] [Related]
5. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
Elgafor el Sharkwy IA
Arch Gynecol Obstet; 2013 Dec; 288(6):1231-6. PubMed ID: 23689739
[TBL] [Abstract][Full Text] [Related]
6. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
Al-Sawaf A; El-Mazny A; Shohayeb A
J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857
[TBL] [Abstract][Full Text] [Related]
8. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
[TBL] [Abstract][Full Text] [Related]
9. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
Vimala N; Mittal S; Kumar S
Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
[TBL] [Abstract][Full Text] [Related]
10. Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial.
Bellad MB; Tara D; Ganachari MS; Mallapur MD; Goudar SS; Kodkany BS; Sloan NL; Derman R
BJOG; 2012 Jul; 119(8):975-82; discussion 982-6. PubMed ID: 22703421
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.
Singh G; Radhakrishnan G; Guleria K
Int J Gynaecol Obstet; 2009 Nov; 107(2):130-4. PubMed ID: 19628206
[TBL] [Abstract][Full Text] [Related]
12. Sublingual misoprostol to decrease blood loss after caesarean delivery: a randomised controlled trial.
Ugwu IA; Enabor OO; Adeyemi AB; Lawal OO; Oladokun A; Olayemi O
J Obstet Gynaecol; 2014 Jul; 34(5):407-11. PubMed ID: 24724983
[TBL] [Abstract][Full Text] [Related]
13. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.
Lam H; Tang OS; Lee CP; Ho PC
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):647-50. PubMed ID: 15225189
[TBL] [Abstract][Full Text] [Related]
14. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
Raghavan S; Abbas D; Winikoff B
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912
[TBL] [Abstract][Full Text] [Related]
15. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
[TBL] [Abstract][Full Text] [Related]
16. A randomised placebo controlled trial of oral misoprostol in the third stage of labour.
Hofmeyr GJ; Nikodem VC; de Jager M; Gelbart BR
Br J Obstet Gynaecol; 1998 Sep; 105(9):971-5. PubMed ID: 9763047
[TBL] [Abstract][Full Text] [Related]
17. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
Owonikoko KM; Arowojolu AO; Okunlola MA
J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
[TBL] [Abstract][Full Text] [Related]
18. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
[TBL] [Abstract][Full Text] [Related]
19. Misoprostol versus oxytocin for the reduction of postpartum blood loss.
Baskett TF; Persad VL; Clough HJ; Young DC
Int J Gynaecol Obstet; 2007 Apr; 97(1):2-5. PubMed ID: 17321529
[TBL] [Abstract][Full Text] [Related]
20. Side-effects of oral misoprostol in the third stage of labour--a randomised placebo-controlled trial.
Hofmeyr GJ; Nikodem VC; de Jager M; Drakely A
S Afr Med J; 2001 May; 91(5):432-5. PubMed ID: 11455810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]